The number of HeartMate II implants shipped has increased from...

The number of HeartMate II implants shipped has increased from 506 in 2006 to 3,149 in 2011. The share of those being used for DT has grown to 40% in 2011 from 20% in 2009.

"We've set a goal for the VAD (Ventricular Assist Device) market to approach 10,000 implants by 2015, which would imply strong upper-teens growth," said Gary Burbach, President and CEO of Thoratec. "HeartMate II should drive that growth across a broad range of geographies and in particular through development of the Destination Therapy opportunity, where Thoratec is investing heavily in efforts to increase awareness of this important therapy."http://news.investors.com/business-the-new-america/073112-620403-thoratec-heartmate-pump-destination-therapy.htm?p=full


Read More At IBD: http://news.investors.com/business-the-new-america/073112-620403-thoratec-heartmate-pump-destination-therapy.htm#ixzz2Csa6pigX